In the UK, Ozempic is licensed specifically for type 2 diabetes, while Wegovy (semaglutide 2.4mg) is the licensed formulation for weight management
However, worth noting, Retatrutide remains a research compound only , it isnt approved for any therapeutic use, and all comparisons refer strictly to pre-clinical research findings
And because the drugs health benefits may take years to materialize such as averting a future heart attack the long-term financial advantages could accrue to other insurers
Postgraduate Medicine , 134 (1), 1419
Explore Weight Loss Solutions At Aponi Aesthetics In Worcester, MA Take the first step towards a healthier and more confident you in 2025 by visiting Aponi Aesthetics
Inflammation Helps calm the recovery process